Well Differentiated Liposarcoma
2 clinical trials · Condition
◉ Watch Well Differentiated Liposarcoma
| Record | Firm | Date |
|---|---|---|
| A Study of Mirdametinib in Combination With Palbociclib in People With Liposarcoma (NCT06843967) | Memorial Sloan Kettering Cancer Center | 2025-02-19 |
| NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS) (NCT06239272) | St. Jude Children's Research Hospital | 2024-03-27 |
Track Well Differentiated Liposarcoma automatically
Every clearance here is in the API, with alerts when new ones post.